Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

CRISPR-Cas9 ... Guided by RNA, the Cas9 endonuclease breaks DNA at a target sequence. Imprecise repair of the double strand break can result in insertion or deletion mutations, while repair ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Researchers have developed a novel DNA base editing technology that allows precise genetic changes in Lactobacillus strains ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Base editing to get cell therapies on point While a traditional CRISPR-Cas9 platform cleaves both ... including pre-clinical correction of gene mutations underlying progeria, glycogen storage ...

The field of fruit ripening involves complex interactions among metabolites that are regulated by various genetic factors, ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

Unless the man-made mutation conveyed some strong evolutionary advantage—and the whole point was to do the opposite ... well as the accuracy that set CRISPR-Cas9 apart from other gene-editing ...

The field of genetic engineering has been fundamentally altered by the advent of Clustered Regularly Interspaced Short Palindromic Repeats, more commonly known as CRISPR ... potential for correcting ...

Similarly PSEN2 mutations can lead to AD pathology ... CRISPR/Cas9 and its role in CNS-related disorders While several functional capabilities of CRISPR/Cas9 point to its role and significance in a ...